No Data
No Data
Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services' (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests
Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx) program. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO), an AI-driven
10-Q: Quarterly report
Express News | Cardio Diagnostics Holdings, Inc. Now Offers Clinical Tests At Walmart's Family Medicine Specialists' Clinic In Round Lake Beach, Illinois, With Walk-In Availability Seven Days A Week
Express News | Cardio Diagnostics Announces Publication Of Results From Budget Impact Modeling Study For PrecisionCHD
Cardio Diagnostics Announces Publication of Study Showing That Its PrecisionCHD Test Could Save Health Insurers Over $113 Million Annually
The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD Test for the Detection and Management of Coronary Heart Disease, which is One of the Largest Cost Centers for Public
Sector Update: Health Care Stocks Advance Late Afternoon
Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index rising 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%. The iShares Biotechnology ETF (IBB) dec
No Data